Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis

Haghikia A, Hegelmaier T, Wolleschak D, Böttcher M, Pappa V, Motte J, Borie D, Gold R, Feist E, Schett G, Mougiakakos D (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

DOI: 10.1136/ard-2024-226017

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Otto-von-Guericke-Universität Magdeburg DE Germany (DE) Ruhr-Universität Bochum (RUB) DE Germany (DE) Kyverna Therapeutics, Inc. US United States (USA) (US)

How to cite

APA:

Haghikia, A., Hegelmaier, T., Wolleschak, D., Böttcher, M., Pappa, V., Motte, J.,... Mougiakakos, D. (2024). Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2024-226017

MLA:

Haghikia, Aiden, et al. "Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis." Annals of the Rheumatic Diseases (2024).

BibTeX: Download